0001493152-24-007266.txt : 20240221 0001493152-24-007266.hdr.sgml : 20240221 20240220175715 ACCESSION NUMBER: 0001493152-24-007266 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240221 DATE AS OF CHANGE: 20240220 EFFECTIVENESS DATE: 20240221 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Ensysce Biosciences, Inc. CENTRAL INDEX KEY: 0001716947 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 822755287 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-505663 FILM NUMBER: 24655364 BUSINESS ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 BUSINESS PHONE: (858) 263-4196 MAIL ADDRESS: STREET 1: 7946 IVANHOE AVENUE STREET 2: SUITE 201 CITY: LA JOLLA STATE: CA ZIP: 92037 FORMER COMPANY: FORMER CONFORMED NAME: Leisure Acquisition Corp. DATE OF NAME CHANGE: 20170913 D 1 primary_doc.xml X0708 D LIVE 0001716947 Ensysce Biosciences, Inc. 7946 IVANHOE AVE, SUITE 201 LA JOLLA CA CALIFORNIA 92037 (858) 263-4196 DELAWARE None Leisure Acquisition Corp. Corporation true D Lynn Kirkpatrick 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Director Bob Gower 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director William Chang 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Andrew Benton 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Steve Martin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Adam Levin 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Curtis Rosebraugh 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director David Humphrey 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Executive Officer Lee Rauch 7946 Ivanhoe Ave, Suite 201 La Jolla CA CALIFORNIA 92037 Director Other Health Care Decline to Disclose 06b false 2024-02-14 false true false 0 H.C. Wainwright & Co., LLC 375 None None 430 PARK AVENUE NEW YORK NY NEW YORK 10022 NY NEW YORK false 4718295 4718295 0 (i) warrants to purchase 7,203,504 shares of common stock issued in return of exercise of outstanding warrants to purchase 3,601,752 shares of common stock and (ii) warrants to the placement agent for 252,123 shares false 4 265950 0 (i) $200,000 cash fee, (ii) $20,000 for non-accountable expenses, (iii) $30,000 for legal expenses, (iv) $15,950 for clearing fees and (v) warrants to purchase 252,123 shares (7% of the shares placed) at an exercise price of $1.6375 per share 0 false Ensysce Biosciences, Inc. /s/ Lynn Kirkpatrick Dr. Lynn Kirkpatrick President and CEO 2024-02-20